Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Clicks: 606
ID: 118051
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Reference Key
m2017journalthird Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Harbord M;Eliakim R;Bettenworth D;Karmiris K;Katsanos K;Kopylov U;Kucharzik T;Molnár T;Raine T;Sebastian S;de Sousa HT;Dignass A;Carbonnel F; ;;
Journal journal of crohn's & colitis
Year 2017
DOI
DOI not found
URL
https://www.pubmed.gov/28513805/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine Remission Induction evidence-based medicine Colitis Ulcerative / drug therapy* Gastrointestinal Agents / therapeutic use* drug therapy combination practice guideline anti-inflammatory agents non-steroidal / therapeutic use* maintenance chemotherapy consensus pmid:28513805 doi:10.1093/ecco-jcc/jjx009 marcus harbord rami eliakim european crohn’s and colitis organisation [ecco] adrenal cortex hormones / administration & dosage adrenal cortex hormones / therapeutic use* non-steroidal / administration & dosage biological products / therapeutic use colon descending sigmoid immunosuppressive agents / therapeutic use* mesalamine / administration & dosage mesalamine / therapeutic use* proctitis / drug therapy tumor necrosis factor-alpha / antagonists & inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.